Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 09 - 10 crawled time : 16:20 save search
Lyra Therapeutics Announces Additional Data Presentations from Phase 2 LANTERN Study at the American Rhinologic Society Annual Meeting
Published: 2022-09-10 (Crawled : 16:20) - prnewswire.com
LYRA | $5.23 0.38% 0.38% 120K
|
Health Technology
| Email alert
Add to watchlist
meeting therapeutics study phase 2
I-Mab Announces Positive Phase 2 Data of Lemzoparlimab in Combination with Azacitidine (AZA) in Patients with Higher Risk Myelodysplastic Syndrome at ESMO 2022
Published: 2022-09-10 (Crawled : 16:20) - prnewswire.com
IMAB | $1.805 0.28% 0.28% 110K
|
Health Technology
| Email alert
Add to watchlist
risk positive phase 2
Omnicom to Present at the Goldman Sachs Communacopia Conference
Published: 2022-09-10 (Crawled : 16:20) - prnewswire.com
OMC | $95.98 1.87% 0.0% 2.2M
|
Commercial Services
| Email alert
Add to watchlist
conference
SpringWorks Therapeutics Announces Data from Phase 3 DeFi Trial Evaluating Nirogacestat in Adult Patients with Progressing Desmoid Tumors at the European Society for Medical Oncology (ESMO) Congress 2022
Published: 2022-09-10 (Crawled : 16:20) - globenewswire.com
SWTX | $43.37 -1.43% -1.45% 470K
|
Health Technology
| Email alert
Add to watchlist
trial therapeutics
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.